Skip to main content
Erschienen in: International Cancer Conference Journal 2/2015

01.04.2015 | Case report

Submucosal layer invasion of squamous cell carcinoma in situ and its differentiation to endocrine cell carcinoma in a case of superficial carcinoma at the esophagogastric junction

verfasst von: Mototsugu Matsunaga, Tsutomu Daa, Katsuhisa Harada, Kazuki Okamura, Tsuyoshi Noguchi

Erschienen in: International Cancer Conference Journal | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Endocrine cell carcinoma (ECC) of the esophagogastric region is a rare malignancy with varied etiologies. In this report, we describe a 64-year-old patient in whom a superficial carcinoma at the esophagogastric junction was detected via endoscopy. No metastasis was noted, and the patient underwent total gastrectomy. During a 1-year follow-up, there was no evidence of recurrence or metastasis. Upon histological analysis, the lesion was found to comprise squamous cell carcinoma (SCC) with an in situ component and a component that had invaded the submucosal layer, in addition to an ECC component. There was no indication of a collision carcinoma, and Nanog negativity excluded the possibility that a cancer stem cell etiology could explain the different cell types. The evidence suggested differentiation from SCC to ECC during the progression to invasive SCC. We describe the possibility of SCC differentiation into ECC and discuss the associated controversial issues.
Literatur
1.
Zurück zum Zitat Japan Esophageal Society (2007) Japanese classification of esophageal cancer, 10th edn. Kanehara & Co., Ltd., Tokyo Japan Esophageal Society (2007) Japanese classification of esophageal cancer, 10th edn. Kanehara & Co., Ltd., Tokyo
2.
Zurück zum Zitat Siewert JR, Stein HJ (1996) Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus 9:173–182 Siewert JR, Stein HJ (1996) Adenocarcinoma of the gastroesophageal junction: classification, pathology and extent of resection. Dis Esophagus 9:173–182
3.
Zurück zum Zitat The Japanese Society for Esophageal Diseases (2002) Comprehensive registry of esophageal cancer in Japan (1998, 1999) and long-term results of esophagectomy in Japan (1988–1997), 3rd edn. http://www.esophagus.jp/crec.html. Accessed 8 Feb 2014 The Japanese Society for Esophageal Diseases (2002) Comprehensive registry of esophageal cancer in Japan (1998, 1999) and long-term results of esophagectomy in Japan (1988–1997), 3rd edn. http://​www.​esophagus.​jp/​crec.​html. Accessed 8 Feb 2014
4.
Zurück zum Zitat Stein HJ, Feith M, Siewert JR (2000) Cancer of the esophagogastric junction. Surg Oncol 9:35–41CrossRefPubMed Stein HJ, Feith M, Siewert JR (2000) Cancer of the esophagogastric junction. Surg Oncol 9:35–41CrossRefPubMed
5.
Zurück zum Zitat Kusano C, Gotoda T, Khor CJ et al (2008) Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary center in Japan. J Gastroenterol Hepatol 23:1662–1665CrossRefPubMed Kusano C, Gotoda T, Khor CJ et al (2008) Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary center in Japan. J Gastroenterol Hepatol 23:1662–1665CrossRefPubMed
6.
Zurück zum Zitat Chandrasoma PT, Der R, Ma Y et al (2000) Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 24:402–409CrossRefPubMed Chandrasoma PT, Der R, Ma Y et al (2000) Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 24:402–409CrossRefPubMed
7.
Zurück zum Zitat Park YS, Park HJ, Kang GH et al (2003) Histology of gastroesophageal junction in fetal and pediatric autopsy. Arch Pathol Lab Med 127:451–455PubMed Park YS, Park HJ, Kang GH et al (2003) Histology of gastroesophageal junction in fetal and pediatric autopsy. Arch Pathol Lab Med 127:451–455PubMed
8.
Zurück zum Zitat Sarbia M, Donner A, Gabbert HE (2002) Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol 26:1207–1212CrossRefPubMed Sarbia M, Donner A, Gabbert HE (2002) Histopathology of the gastroesophageal junction: a study on 36 operation specimens. Am J Surg Pathol 26:1207–1212CrossRefPubMed
9.
Zurück zum Zitat Rice TW, Rusch VW, Ishwaran H et al (2010) Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer 116:3763–3773CrossRefPubMed Rice TW, Rusch VW, Ishwaran H et al (2010) Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer 116:3763–3773CrossRefPubMed
10.
Zurück zum Zitat Tateishi R, Taniguchi K, Horai T et al (1976) Argyrophil cell carcinoma (apudoma) of the esophagus. A histopathologic entity. Virchows Arch A Pathol Anat Histol 371:283–294CrossRefPubMed Tateishi R, Taniguchi K, Horai T et al (1976) Argyrophil cell carcinoma (apudoma) of the esophagus. A histopathologic entity. Virchows Arch A Pathol Anat Histol 371:283–294CrossRefPubMed
11.
Zurück zum Zitat Imai T, Sannohe Y, Okano H (1978) Oat cell carcinoma (apudoma) of the esophagus: a case report. Cancer 41:358–364CrossRefPubMed Imai T, Sannohe Y, Okano H (1978) Oat cell carcinoma (apudoma) of the esophagus: a case report. Cancer 41:358–364CrossRefPubMed
12.
Zurück zum Zitat Law SY, Fok M, Lam KY et al (1994) Small cell carcinoma of the esophagus. Cancer 73:2894–2899CrossRefPubMed Law SY, Fok M, Lam KY et al (1994) Small cell carcinoma of the esophagus. Cancer 73:2894–2899CrossRefPubMed
13.
Zurück zum Zitat Soga J (1998) Esophageal endocrinomas, an extremely rare tumor; a statistical comparative evaluation of 28 ordinary carcinoid and 72 atypical variants. J Exp Clin Cancer Res 17:45–57 Soga J (1998) Esophageal endocrinomas, an extremely rare tumor; a statistical comparative evaluation of 28 ordinary carcinoid and 72 atypical variants. J Exp Clin Cancer Res 17:45–57
14.
Zurück zum Zitat Maru DM, Khurana H, Rashid A et al (2008) Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32:1404–1411CrossRefPubMed Maru DM, Khurana H, Rashid A et al (2008) Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32:1404–1411CrossRefPubMed
15.
Zurück zum Zitat Huang Q, Wu H, Nie L et al (2013) Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol 37:467–483CrossRefPubMed Huang Q, Wu H, Nie L et al (2013) Primary high-grade neuroendocrine carcinoma of the esophagus: a clinicopathologic and immunohistochemical study of 42 resection cases. Am J Surg Pathol 37:467–483CrossRefPubMed
16.
Zurück zum Zitat Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655CrossRefPubMed Chambers I, Colby D, Robertson M et al (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113:643–655CrossRefPubMed
17.
Zurück zum Zitat Mitsui K, Tokuzawa Y, Itoh H et al (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631–642CrossRefPubMed Mitsui K, Tokuzawa Y, Itoh H et al (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:631–642CrossRefPubMed
18.
Zurück zum Zitat Pan G, Thomson JA (2007) Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17:42–49CrossRefPubMed Pan G, Thomson JA (2007) Nanog and transcriptional networks in embryonic stem cell pluripotency. Cell Res 17:42–49CrossRefPubMed
19.
Zurück zum Zitat Matsuoka J, Yashiro M, Sakurai K et al (2012) Role of the stemness factors sox2, oct3/4, and Nanog in gastric carcinoma. J Surg Res 174:130–135CrossRefPubMed Matsuoka J, Yashiro M, Sakurai K et al (2012) Role of the stemness factors sox2, oct3/4, and Nanog in gastric carcinoma. J Surg Res 174:130–135CrossRefPubMed
20.
Zurück zum Zitat Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72CrossRefPubMed Modlin IM, Oberg K, Chung DC et al (2008) Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 9:61–72CrossRefPubMed
21.
Zurück zum Zitat Uchida Y, Roessner A, Schlake W et al (1976) Development of tumors in the glandular stomach of rats after oral administration of carcinogens. II. Different cell types in antral carcinoma as revealed by electron microscopy. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87:213–228CrossRefPubMed Uchida Y, Roessner A, Schlake W et al (1976) Development of tumors in the glandular stomach of rats after oral administration of carcinogens. II. Different cell types in antral carcinoma as revealed by electron microscopy. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol 87:213–228CrossRefPubMed
22.
Zurück zum Zitat Franchi A, Rocchetta D, Palomba A et al (2013) Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. doi:10.1007/s12105-013-0513-5 PubMed Franchi A, Rocchetta D, Palomba A et al (2013) Primary combined neuroendocrine and squamous cell carcinoma of the maxillary sinus: report of a case with immunohistochemical and molecular characterization. Head Neck Pathol. doi:10.​1007/​s12105-013-0513-5 PubMed
23.
Zurück zum Zitat Nishimura M, Kaiho T, Yanagisawa S et al (2012) A case of recurrent hepatic resection after surgery for esophageal cancer with neuroendocrine component. Jpn J Gastroenterol Surg 45:359–368CrossRef Nishimura M, Kaiho T, Yanagisawa S et al (2012) A case of recurrent hepatic resection after surgery for esophageal cancer with neuroendocrine component. Jpn J Gastroenterol Surg 45:359–368CrossRef
Metadaten
Titel
Submucosal layer invasion of squamous cell carcinoma in situ and its differentiation to endocrine cell carcinoma in a case of superficial carcinoma at the esophagogastric junction
verfasst von
Mototsugu Matsunaga
Tsutomu Daa
Katsuhisa Harada
Kazuki Okamura
Tsuyoshi Noguchi
Publikationsdatum
01.04.2015
Verlag
Springer Japan
Erschienen in
International Cancer Conference Journal / Ausgabe 2/2015
Elektronische ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-014-0181-7

Weitere Artikel der Ausgabe 2/2015

International Cancer Conference Journal 2/2015 Zur Ausgabe

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.